During the past decade, Institute for Clinical Effectiveness and Health Policy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Clinical Effectiveness and Health Policy" #1 collaborator was "Institute for Clinical Effectiveness and Health Policy" with 4 trials as a collaborator, "Instituto de Efectividad Clinica y Sanitaria (IECS)" with 1 trials as a collaborator, "Instituto de Enfermedades Infecciosas y Parasitol Antonio Vidal" with 1 trials as a collaborator, "Kinshasa School of Public Health" with 1 trials as a collaborator and "Lab de Parasitologia Universidad Autonoma de Yucatan" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Clinical Effectiveness and Health Policy" are "Chagas Disease" (2 trials), "Hypertension" (2 trials), "Acute Stress Disorder" (1 trials), "Congenital Syphilis" (1 trials) and "Prehypertension" (1 trials). Many other conditions were trialed in "Institute for Clinical Effectiveness and Health Policy" in a lesser frequency.

Most popular intervention types in "Institute for Clinical Effectiveness and Health Policy" are "Behavioral" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Benznidazole" (1 trials), "Comprehensive Intervention" (1 trials), "Congenital Syphilis Intervention Group" (1 trials), "Mobile technology to promote lifestyle modification" (1 trials) and "Online survey" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Clinical Effectiveness and Health Policy" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Institute for Clinical Effectiveness and Health Policy". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Institute for Clinical Effectiveness and Health Policy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Clinical Effectiveness and Health Policy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".